If not administered properly, health experts say medications like Ozempic, Mounjaro, and Wegovy can cause gastrointestinal ...

Dr. Philip A. Chan joined GoLocal to discuss the new wave of weight loss drugs and their implications for fighting obesity as well as their implications for other applications like kidney disease and ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...

Discover Veru Inc.'s latest Q1 2025 updates on enobosarm & sabizabulin trials, financials, & strategic pivots in cardiometabolic and inflammation treatment.

More and more Americans are turning to GLP-1 injections to lose weight. FOX 7 Austin's Rebecca Thomas spoke to an Austin physician to discuss.

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are ca ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

Even so, side effects for both drugs tend to be mild with less than ... Victoza and Ozempic are two injectable GLP-1 agonists used to treat type 2 diabetes. They also help lower the risk of stroke and ...